To read a special commentary from Mark E. Rupp, MD, president of SHEA, CLICK HERE.
The Association for Professionals in Infection Control and Epidemiology (APIC) announced today that the organization, along with SHEA and the IDSA, have issued a letter to President Obama expressing concern over the current federal guidance surrounding the use of personal protective equipment (PPE) by healthcare workers in treating suspected or confirmed cases of 2009 H1N1 influenza.
According to APIC’s statement issued today, the letter was precipitated by a re-evaluation of a study performed in China (MacIntyre, et al.) presented last week in which no significant differences were observed among healthcare workers wearing surgical masks or N95 respirators. Of note, the MacIntyre study was initially reported to show a significant benefit associated with the use of N95 respirators. This preliminary report was cited in the Institute of Medicine’s Sept. 3, 2009 Letter Report, which recommended the routine use of N95 respirators.
APIC reports that in its letter, it urged Obama and his administration to modify the guidance to reflect the position best supported by the available science – which is first-line use of surgical masks for routine H1N1 patient care. The letter also requests an immediate moratorium on OSHA’s requirement for healthcare facilities related to the use of N95 respirators in relation to H1N1 influenza. It was pointed out that permitting OSHA to continue to enforce a policy not grounded in science will force healthcare facilities to waste time and resources while working to comply with this requirement, rather than to enact measures that will significantly benefit patient care and healthcare worker safety during this national emergency.
Additionally, the communiqué expresses concern over the existing shortage of respirators, potentially precluding their use in situations where they are most needed. The letter detailed the advantages of surgical masks by providing appropriate protection for all routine patient encounters, and concludes by offering APIC's collective support in responding to the 2009 H1N1 pandemic.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.